CenterCenter website

Englander Institute for Precision Medicine

The Englander Institute for Precision Medicine is a large multi-disciplinary institute that uses precision medicine technologies and informatics to uncover the molecular mechanisms of disease and individualize disease treatment and prevention.

OEDirectorOlivier ElementoDirector of the Englander Institute for Precision Medicine

Top research areas

Translational & Clinical Science506 Cell & Molecular Biology495 Genetics, Genomics & Precision Medicine476

58 scholars8,329 publications

Spotlight

Prostate & Urologic Cancer

STScott T. Tagawa HBHimisha Beltran MJMichael J. Morris

Lancet (London, England) · 2026

Gastrointestinal Cancer

MAManish A Shah

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026

Lung Cancer

NKNasser K Altorki JLJeffrey L Port TWThomas William Bauer

The New England journal of medicine · 2023

View all 8,329 publications →

Scholars58 Publications8,329 Grants204

Showing 1–20 of 204 active grants

American Thyroid Association, Inc. · ATA 261007-01
Theranostic 89Zr/225Ac anti-CEACAM5 radioimmunotherapy for metastatic medullary thyroid cancer
STScott T. Tagawa
2026–2028
Breast Cancer Research Foundation, Inc. · BCRF-26-053
Optimization of immune checkpoint inhibition during radiation-induced vaccination in breast cancer
SCSilvia Chiara Formenti
2026–2028
Breast Cancer Research Foundation, Inc. · BCRF-26-194
International Center for the Study of Breast Cancer Subtypes: A Unique Biobank and Research/Training Program
LALisa Ann Newman
2026–2027
United States Department of Defense · HT9425-26-1-E164
Targeted Therapies
STScott T. Tagawa
2026–2030
National Institute on Aging · 1 R56 AG095450-01A1
Prime Editing of CNS APOE4 to APOE2 or APOE3Christchurch to Suppress Alzheimer's Disease APOE4-associated Amyloid and Tau Pathology
JMJason Mezey
2026–2027
National Institute of Child Health & Human Development · 1 R61 HD123536-01
AI-Driven Embryo Selection Platform for Enhanced Implantation in IVF: A Phased Development and Randomized Clinical Trial
IHIman Hajirasouliha
2026–2028
National Inst of Arthritis & Musculoskeletal & Skin Diseases · 2 R01 AR077664-06
Mechanisms of cAMP-dependent regulation of melanosome pH
JZJonathan Zippin
2026–2031
National Cancer Institute · 1 DP1 CA324880-01
AI-Human Discovery Engines for Mechanistic Cancer Biology
OEOlivier Elemento
2026–2031
National Cancer Institute · 1 R01 CA316570-01
Anti-PD1 driven tissue pathogenesis, towards preventing and treating irAE toxicity during cancer therapy
NANiroshana Anandasabapathy
2026–2031
National Institute of Mental Health · 1 P30 MH144896-01
New York-New Jersey Center for Actionable NeuroHIV Biomarkers and Integrated Omics (NYJ-CAN-BIO)
HAHoward Alan Fine
2026–2030
National Cancer Institute · 1 R37 CA304192-01A1
The role of MGA in the pathogenesis of Richter Transformation
DADan Avi Landau
2026–2031
National Cancer Institute · 1 R01 CA311885-01
Caloric restriction to enhance cancer immunoprevention
OEOlivier Elemento
2026–2031
Bladder Cancer Advocacy Network, Inc. · BCAN 1660936
Environmental Polycyclic Aromatic Hydrocarbon Exposure Drives APOBEC3-Mediated Mutagenesis and Bladder Carcinogenesis
BMBishoy Morris Faltas
2026–2028
Bladder Cancer Advocacy Network, Inc. · BCAN 1659349
Targeting APOBEC3A-driven transcriptional reprogramming to prevent metastasis in bladder cancer
BMBishoy Morris Faltas
2026–2028
National Institute of Diabetes & Digestive & Kidney Diseases · 1 R01 DK144473-01A1
A basic mechanism contributing to human insulin resistance and diabetes: role of the essential amino acid sensor SLC36A4 in GLUT4 trafficking in adipocytes
TETimothy E. McGraw
2026–2028
The Asco Cancer Foundation · ASCO 253876-01
Characterizing the Impact of Clonal Hematopoiesis on Tumor Genomics and Clinical Outcomes in Solid Cancers
PDPinkal Desai
2026–2027
The Asco Cancer Foundation · ASCO 253887-01
Development and application of an artificial intelligence (AI) foundation model for somatic variants in cancer
MAManish A Shah
2026–2027
Sergey Brin Family Foundation via Research Foundation for Mental Hygiene, Inc. · ARIA-IMPACT-006
ARIA IMPACT (Aligning Research to Impact Autism Innovative Medicine and Precision Approaches to Clinical Trials) Network Grant
OAOmar Abdul-Rahman
2026–2027
American Society of Hematology Inc · ASH 260104-01
Tracking clonal hematopoiesis dynamics after CAR-T using deep next-generation DNA sequencing of genes associated with myeloid and lymphoid CHIP (prelim title)
PDPinkal Desai
2026–2027
American Urological Association · 1614289
The role of SPOP mutation in opposing lineage plasticity in neuroendocrine prostate cancer
CBChristopher Barbieri
2026–2028

Englander Institute for Precision Medicine

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer